Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Inspire can be removed if it is not tolerated, but it should also be tried only if someone is unable to use CPAP, and it is not an option for everyone. A new study, recently published in the New ...

I’ve been diagnosed with sleep apnea and have been trying to use a CPAP device for the past six months but can’t tolerate it. Are there any ...

Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...

(Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that ...

Among potential surgeries for sleep apnea is UPPP (uvulopalatopharyngoplasty) surgery, which involves removing part of the ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Inspire expects full-year earnings to be $1.20 to $1.40 per share, with revenue in the range of $793 million to $798 million. This story was generated by Automated Insights ( ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...